Hong Wei Chu, MD Ask a Question Refer Patient Hong Wei Chu, MD, is a pulmonologist at National Jewish Health. Dr. Chu serves as Head of the Basic Science Section. Assistant Vice President for Academic Affairs for Research Infrastructure Head, Basic Science Section Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine 5280 Top Doctors 2020 Previously a 5280 Top Doctor America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd. Recognized in America’s Top Doctors — Castle Connolly, Inc. Best Doctors in America® 2019-2020 — Best Doctors, Inc. Recognized in Best Doctors in America® — Best Doctors, Inc. America’s Top Doctors 2020 — Castle Connolly Medical, Ltd. Email Profile Print Profile Overview Contact Info & Locations Programs & Services Department of Medicine Division of Pulmonary, Critical Care and Sleep Medicine (Adult) Research Areas Airway Epithelial Cell Biology Respiratory bacterial and viral infections in asthma and COPD Asthma Chronic Obstructive Pulmonary Disease (COPD) Special Interests Airway epithelial cell host defense functions against bacterial and viral infections in asthma and COPD. Research Interests Dr. Chu’s laboratory studies the innate immunity of lung cells such as epithelial cells and macrophages in asthma and COPD. Particularly, Dr. Chu focuses on revealing the mechanisms underlying the increased susceptibility to respiratory infections of bacteria and viruses in airways of asthma and COPD patients. News & Videos National Jewish Health Awarded $11.5 Million in Department of Defense Grants Study Links The Liquid Used In E-cigarettes To An Increased Risk Of Viral Infections Education Publications Zhang W, Case S, Bowler RP, Martin RJ, Jiang D, Chu HW. Cigarette smoke modulates PGE2 and host defense against Moraxella catarrhalis infection in human airway epithelial cells. Respirology 2011;16:508–516. PMID: 21199162 Wu Q, Jiang D, Minor MN, Martin RJ, Chu HW. In vivo function of airway epithelial TLR2 in host defense against bacterial infection. Am J Physiol Lung Cell Mol Physiol 2011;300:L579–586. PMID: 21239529 Simon GC, Martin RJ, Smith S, Thaikoottathil J, Bowler RP, Barenkamp SJ, Chu HW. Up-regulation of MUC18 in Airway Epithelial Cells by IL-13: Implications inBacterial Adherence. Am J Respir Cell Mol Biol 2011;44:606–613. PMID: 21239604 Gally F, Di YP, Smith SK, Minor MN, Liu Y, Bratton DL, Frasch SC, Michels NM, Case SR, Chu HW. SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice. Am J Pathol 2011;178:2159–2167. PMID: 21514430 Case SR, Martin RJ, Jiang D, Minor MN, Chu HW. MicroRNA-21 inhibits TLR2 agonist-induced lung inflammation in mice. Exp Lung Res 2011, in press. Academic Affiliations Professor, Department of Immunology & Microbiology, University of Colorado Denver Website Information Chu Lab Ask a Question through Patient Portal Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account Contact Information Office: 877.225.5654Fax: 303.270.2319 Locations National Jewish Health Main Campus 1400 Jackson St. Denver, CO 80206 Patient Ratings The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey. Comments Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.